Buy ContraVir Pharmaceuticals Stock | CTRV Stock Price & Latest News | Public
CTRV

ContraVir Pharmaceuticals

    We couldn’t load this chart.

    Some stock charts might currently not be supported. To try again, please refresh this page.

    About CTRV

    Hepion Pharmaceuticals, Inc. engages in the development and commercialization of pleiotropic drug therapy for the treatment of chronic liver disease. It focuses on the development of its product candidate CRV431, a cyclophilin inhibitor that targets biochemical pathways...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    Stats

    Market Cap$14,25M
    Volume
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$7.60
    1 Year Low$1.00
    Open
    High
    Low

    Buy any stock with any amount of money.

    Download the App
    Download the app